Swiss-based company founded in 2007 providing companion diagnostics devices to the gastroenterology medical community. First product launched under brand Simtomax®, a rapid IVD test for the early screening of Celiac Disease, marketed in 14 countries and currently under registration at the FDA with launch in the US in 2014. Developing in partnership with ETHZ and Uni Zurich new biomarkers for the accurate in-vitro and in-vivo diagnostic of IBD.